Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

Fitch Revises Outlook on Shriram Transport Finance to Stable, Affirms at 'BB'

Posted On: 2021-09-16 13:15:15 (Time Zone: IST)

Fitch Ratings has revised the Outlook on India-based Shriram Transport Finance Company Limited's (STFC) Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDR) to Stable, from Negative, and has affirmed the ratings at 'BB'.

STFC's ratings reflect the company's longstanding franchise in used commercial-vehicle financing, experienced management, satisfactory execution record backed by established underwriting processes and risk controls, and improved loss-absorption buffers.

We have revised the Outlook to Stable as we believe STFC's credit profile is likely to remain resilient, despite lingering uncertainty in the macroeconomic outlook due to the Covid-19 pandemic. STFC's operating metrics have improved since the second half of fiscal year ended March 2021 (FY21) and it has maintained steady funding access, which we expect will be sustained. The company has strengthened its capital adequacy, liquidity and provisioning buffers over the past year, further improving its defences against credit impairment and refinancing risk.

STFC's high non-performing loan (NPL) ratio of 8.2% at end-June 2021 (FYE20: 8.5%) reflects its exposure to sub-prime borrowers who fall outside banks' typical customer base. The company adopts a more accommodative approach in recovering past-due loans, based on its experience that delinquent borrowers are often able to repay if allowed more time to do so. This, along with its largely secured loan book, explains its lower credit losses of around 2.7% of loans in FY21 (FY20: 2.5%) - which include pre-emptive provisions to cushion against pandemic-led uncertainties. Moreover, STFC's provision coverage ratio improved to 93% of NPLs in June 2021 (FYE20: 68%), forming a wider loss-absorption buffer against future impairment.

STFC's rural and semi-urban customer base underpins its high net interest margin. This, along with its moderate operating expense base, resulted in healthy pre-provisioning profitability to gross loans of around 5.6% in FY21 (FY20: 5.8%), helping to compensate for the higher impairment risk in its loan book. Fitch expects earnings to remain supported in the medium-term through sustained volume growth, careful margin and operating expense management and adequately contained credit costs.

STFC's leverage improved to 4.6x by end-June 2021, from 5.0x at end-March 2021 as STFC was able to raise a total of INR37.5 billion in equity capital since August 2020. This has strengthened its capital loss-absorption buffers against unexpected losses; its tier 1 capital adequacy ratio increasing to 21% by end-June 2021, from 18% at end-March 2020. Fitch expects little pressure on leverage in near term as internal capital generation should substantially be able to support STFC's loan growth targets.

STFC's longer-tenor asset portfolio is generally matched against its medium-term funding portfolio. Liquidity buffers have increased relative to a year ago, backed by enlarged holdings of unrestricted cash and liquid assets. We expect the company to pare this buffer back once it is more confident of the macroeconomic outlook. However, it is likely to keep its liquidity buffer commensurate with its rating to cover near-term debt maturities in case of a temporary liquidity squeeze. STFC has maintained adequate access to funding at competitive rates over the past year from diversified sources, including banks, mutual funds, public deposits, securitisation and offshore debt.

The ratings on STFC's medium-term note (MTN) programme and foreign-currency senior secured debt are at the same level as its Long-Term Foreign-Currency IDR, while the rupee denominated senior secured debt is rated at same level as its Long-Term Local-Currency IDR in accordance with Fitch's rating criteria.

Indian non-bank financial institution (NBFI) borrowings are typically secured and Fitch believes that non-payment of senior secured debt would best reflect an entity's uncured failure. NBFIs can issue unsecured debt in the overseas market, but such debt is likely to constitute a small portion of their funding and thus cannot be viewed as a primary financial obligation.

Shares of Shriram Transport Finance Co. Ltd., was last trading in BSE at Rs. 1366.9 as compared to the previous close of Rs. 1352.65. The total number of shares traded during the day was 34239 in over 1604 trades.

The stock hit an intraday high of Rs. 1379.1 and intraday low of 1342.5. The net turnover during the day was Rs. 46492458.

Click here to send ur comments or to

Other Headlines:

TVS Motor Company wins India Green Energy Award

Zuari Agro Chemicals Limited announces shutdown of NPK plants

Metropolis Healthcare completes acquisition of chain of labs in South India called 'Hitech Diagnostic Centre'

Ravi Kumar Distilleries Ltd resumes operations at factory

JK Cement Ltd and PRESPL sign a Strategic MoU to Curate a 'Decarbonisation Path', envisioned for Decade and Beyond

Bank of India opens first ever branch in Leh

Kotak Partners Pine Labs as it scales up its Merchant Acquiring Business

IndiGo transported 67.9% of the vaccines as India touches 100-crore dose milestone

Cybertech Systems and Software Ltd Q2FY22 consolidated PAT at Rs. 8.47 crore

Reliance Industries Ltd Q2FY22 consolidated PAT rises to Rs. 13680 crore

Dodla Dairy Ltd Q2FY22 consolidated net profit drops to Rs. 29.39 crore

Zenotech Laboratories Ltd posts Rs. 94.64 lakhs profit in Q2FY22

Inventure Growth and Securities Ltd Q2FY22 consolidated PAT at Rs. 3.70 crore

The Federal Bank Ltd reports consolidated PAT of Rs. 487.99 crore in Q2FY22

Crompton Greaves Consumer Electricals Ltd Q2FY22 consolidated PAT up at Rs. 158.81 crore

Tata Consumer Products Ltd consolidated Q2FY22 PAT at Rs. 268.04 crores

Pioneer Distilleries Ltd Q2FY22 loss at Rs. 21.79 crore

Tata Elxsi Ltd Q2FY22 net profit rises to Rs. 125.33 crore

Kirloskar Ferrous Industries Ltd posts Rs. 119.91 crores PAT in Q2FY22

Control Print Ltd posts Rs. 9.83 crore consolidated PAT in Q2FY22

Sacheta Metals Ltd Q2FY22 net profit at Rs. 0.42 crore

TCI Developers Ltd reports consolidated PAT at Rs. 14.35 lakhs

Huhtamaki India Ltd reports Q3CY21 loss at Rs. 21.84 crore

Garment Mantra Lifestyle Ltd opens 13th store at Surat, Gujarat

Globalspace Technologies Ltd Board recommends Final Dividend of Rs. 0.20

Prismx Global Ventures Ltd launches 'Gudgudi' The First OTT Channel

2021 TCS New York City Marathon App Lets Fans Enjoy a Hybrid Race Experience

Kranti Industries Ltd receives in-principle approval for migration to main board

B P Capital Ltd allots 30 lakh warrants

NALCO's Lean Slurry Project at Angul

Trimurthi Ltd acquires property in Hyderabad

Wendt India Ltd reports earnings for Q2FY22

Shanthi Gears Limited Q2 Revenue at Rs. 71.8 Crs and PBT Rs. 11.3 Crs

TCS & Shell Recognized with 2021 ISG Digital Case Study Award™ for Digital Transformation

Siemens Limited to procure solar power for Kalwa facility

Surana Solar Ltd invests in Surana Infotech Pvt Ltd

PVR announces results for the Quarter & Half Year ended September 30, 2021

Ramkrishna Forgings Ltd Opens Offices in Russia & Europe to further expand its global footprints

INOX Leisure Ltd - Q2'FY22 Financial Results Highlights

Steel Strips Wheels Ltd fixes Nov 22, 2021 as record date for stock split

Apollo Pipes Ltd Board recommends 2:1 Bonus Issue

TCI Express Ltd Board approves interim dividend of Rs. 3

Supreme Industries Ltd Board declares Interim Dividend of Rs. 6

Kajaria Ceramics Ltd Board declares Interim Dividend of Rs. 8

J. Kumar Infraprojects Ltd JV bags order worth Rs. 205.49 crore

Lupin life signs Hrlthik Roshan as the brand ambassador for Be One, Ayurvedic Energy Supplement

Welspun Corp Signs MoU With BP India Pvt. Ltd.

Adani Renewable Energy Holding Fifteen Ltd receives LOA from SECI for 450MW wind power project

The Indian Hume Pipe Company Limited receives LoA for Rs. 156.27 crores order

Zydus announces 'first patient' randomised in EVIDENCES-X Phase II(b) clinical trial of Saroglitazar Mg in NASH

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020